Table 2.

Observations associated with PD-1 expression on T cells in B-cell lymphomas

ReferenceNo. of PatientsAntibody (manufacturer)Associations
HL    
 41 19 (BD Pharmingen) PD-1 levels in the peripheral blood T cells of HL patients tended to be higher in active disease and declined along with treatment; PD-1 and FOXP3 seemed to be alternatively expressed (expressed in different patients). 
 42 189 AF 1086 (R&D Systems) PD-1+ cell density was lower in patients with 9p24.1 gains (near PDL2 locus) and in those with high numbers of FOXP3+ Tregs but positively correlated with densities of granzyme B+ and TIA-1+ cells. 
 61 280 760-4448 (Ventana Roche) There was no correlation between 9p24.1 alterations, EBV status, and rosetting of PD-1+ T cells in HL. 
FL    
 47 132 NAT105 (Abcam) PD-1 expression in FL tissues correlated with low grade, good performance status, and low LDH; PD-1 expression was alternative to FOXP3 positivity in T cells (expressed in different patients). 
 46 49 Polyclonal AF1086 (R&D Systems) The amount of PD-1+ TILs was higher in FL grade 1 to 2 than in FL grade 3 and further decreased in FL with transformation to DLBCL. 
 51 91 NAT (Abcam) The number of PD-1+ cells in FL tissues correlated with the number of FOXP3+ Tregs. 
 55 82 NAT, abcam52587 (Abcam) PD-1 positivity in FL biopsies was associated with male sex and high serum β2M levels. 
 48 14 clone EH12.1 High PD-1 expression levels in TILs correlated with decreased cytokine signaling response, including IL-4–induced phosphorylation of STAT6 and IL-10/IL-21–induced phosphorylation of STAT3. 
 52 32 ab52587 (Abcam) Intratumoral PD-1high T cells: CD4+CXCR5+BCL-6+TIM-3; PD-1low T cells: TIM-3+BCL-6CXCR5
CLL    
 69 77 (BD Biosciences) CLL patients with inverted CD4:CD8 ratios had significantly increased PD-1 levels on CD8+ T cells in CLL blood samples. 
DLBCL    
 56 70 Mouse mAb Number of PD-1high (TFH) cells positively correlated with number of CD4+ T cells. 
 57 236 Clone NAT105 (Abcam) The number of PD-1+ TILs was lower in groups of patients with B symptoms, extranodal sites, bulky masses, ABC subtype, and PD-L1+ (≥30%) DLBCL. 
 64 46 (eBioscience) Increased blood PD-1 levels were associated with stage III and IV, B symptoms, IPI >2, elevated LDH, and high Ki-67; PD-1 levels decreased after 4 courses of chemotherapy. 
 61 253 760-4448 (Ventana Roche) Tumor PD-L1 expression levels positively correlated with the amount of PD-1+ TILs in ABC-DLBCL. 
 58 126 Clone MRQ-22 (Cell Marque) The number of PD-1+ TILs positively correlated with PD-L1 expression levels on tumor cells and/or macrophages. 
 62 31  An increased number of PD-1+ TILs negatively correlated with tumor Ki-67 and positively correlated with PD-L1 expression in histiocytes but not with PD-L1 on tumor cells. 
 65 60 Clone MIH4 (phycoerythrin) PD-1 expression in tumor biopsies did not correlate with PD-1 expression in the peripheral blood. 
ReferenceNo. of PatientsAntibody (manufacturer)Associations
HL    
 41 19 (BD Pharmingen) PD-1 levels in the peripheral blood T cells of HL patients tended to be higher in active disease and declined along with treatment; PD-1 and FOXP3 seemed to be alternatively expressed (expressed in different patients). 
 42 189 AF 1086 (R&D Systems) PD-1+ cell density was lower in patients with 9p24.1 gains (near PDL2 locus) and in those with high numbers of FOXP3+ Tregs but positively correlated with densities of granzyme B+ and TIA-1+ cells. 
 61 280 760-4448 (Ventana Roche) There was no correlation between 9p24.1 alterations, EBV status, and rosetting of PD-1+ T cells in HL. 
FL    
 47 132 NAT105 (Abcam) PD-1 expression in FL tissues correlated with low grade, good performance status, and low LDH; PD-1 expression was alternative to FOXP3 positivity in T cells (expressed in different patients). 
 46 49 Polyclonal AF1086 (R&D Systems) The amount of PD-1+ TILs was higher in FL grade 1 to 2 than in FL grade 3 and further decreased in FL with transformation to DLBCL. 
 51 91 NAT (Abcam) The number of PD-1+ cells in FL tissues correlated with the number of FOXP3+ Tregs. 
 55 82 NAT, abcam52587 (Abcam) PD-1 positivity in FL biopsies was associated with male sex and high serum β2M levels. 
 48 14 clone EH12.1 High PD-1 expression levels in TILs correlated with decreased cytokine signaling response, including IL-4–induced phosphorylation of STAT6 and IL-10/IL-21–induced phosphorylation of STAT3. 
 52 32 ab52587 (Abcam) Intratumoral PD-1high T cells: CD4+CXCR5+BCL-6+TIM-3; PD-1low T cells: TIM-3+BCL-6CXCR5
CLL    
 69 77 (BD Biosciences) CLL patients with inverted CD4:CD8 ratios had significantly increased PD-1 levels on CD8+ T cells in CLL blood samples. 
DLBCL    
 56 70 Mouse mAb Number of PD-1high (TFH) cells positively correlated with number of CD4+ T cells. 
 57 236 Clone NAT105 (Abcam) The number of PD-1+ TILs was lower in groups of patients with B symptoms, extranodal sites, bulky masses, ABC subtype, and PD-L1+ (≥30%) DLBCL. 
 64 46 (eBioscience) Increased blood PD-1 levels were associated with stage III and IV, B symptoms, IPI >2, elevated LDH, and high Ki-67; PD-1 levels decreased after 4 courses of chemotherapy. 
 61 253 760-4448 (Ventana Roche) Tumor PD-L1 expression levels positively correlated with the amount of PD-1+ TILs in ABC-DLBCL. 
 58 126 Clone MRQ-22 (Cell Marque) The number of PD-1+ TILs positively correlated with PD-L1 expression levels on tumor cells and/or macrophages. 
 62 31  An increased number of PD-1+ TILs negatively correlated with tumor Ki-67 and positively correlated with PD-L1 expression in histiocytes but not with PD-L1 on tumor cells. 
 65 60 Clone MIH4 (phycoerythrin) PD-1 expression in tumor biopsies did not correlate with PD-1 expression in the peripheral blood. 

Anti-PD-1 clone names were not available in references 41, 64, and 69.

IPI, International Prognostic Index; LDH, lactate dehydrogenase.

Close Modal

or Create an Account

Close Modal
Close Modal